Skip to main content
. 2019 Dec 23;13(2):295–299. doi: 10.1016/j.tranon.2019.12.001

Figure 2.

Figure 2

Progression free survival for patient with metastatic bone sarcoma treated with pazopanib. The number of patients is 19. All patients have at the time of follow-up progressed.